Equities analysts expect that Stericycle, Inc. (NASDAQ:SRCL) will post sales of $902.39 million for the current quarter, Zacks reports. Eight analysts have provided estimates for Stericycle’s earnings, with estimates ranging from $893.70 million to $916.80 million. Stericycle posted sales of $891.62 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 1.2%. The business is expected to issue its next earnings results on Thursday, July 27th.

On average, analysts expect that Stericycle will report full year sales of $902.39 million for the current financial year, with estimates ranging from $3.59 billion to $3.66 billion. For the next financial year, analysts forecast that the company will report sales of $3.68 billion per share, with estimates ranging from $3.64 billion to $3.72 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow Stericycle.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, May 4th. The business services provider reported $1.09 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.04. The firm had revenue of $892.40 million for the quarter, compared to analyst estimates of $874.34 million. Stericycle had a net margin of 5.23% and a return on equity of 14.40%. Stericycle’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period last year, the company posted $1.11 EPS.

A number of analysts recently commented on the stock. Goldman Sachs Group Inc raised shares of Stericycle from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $62.00 to $79.00 in a report on Tuesday, March 7th. Jefferies Group LLC set a $108.00 price target on shares of Stericycle and gave the company a “buy” rating in a report on Saturday, May 6th. Robert W. Baird downgraded shares of Stericycle from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $74.00 to $73.00 in a report on Monday, May 15th. Deutsche Bank AG reduced their price target on shares of Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, May 15th. Finally, Barrington Research upped their price target on shares of Stericycle from $84.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, February 22nd. Three analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $82.17.

Shares of Stericycle (SRCL) traded down 0.24% on Wednesday, reaching $77.94. 42,050 shares of the company were exchanged. The stock has a 50 day moving average of $82.42 and a 200-day moving average of $80.72. The company has a market capitalization of $6.65 billion, a P/E ratio of 40.61 and a beta of 0.15. Stericycle has a 52-week low of $71.52 and a 52-week high of $107.74.

ILLEGAL ACTIVITY WARNING: “$902.39 Million in Sales Expected for Stericycle, Inc. (SRCL) This Quarter” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/06/21/902-39-million-in-sales-expected-for-stericycle-inc-srcl-this-quarter.html.

Large investors have recently added to or reduced their stakes in the company. Pacad Investment Ltd. acquired a new stake in Stericycle during the fourth quarter valued at about $100,000. Kernodle & Katon Asset Management Group LLC acquired a new stake in Stericycle during the first quarter valued at about $100,000. Heritage Trust Co acquired a new stake in Stericycle during the first quarter valued at about $124,000. Pacer Advisors Inc. raised its stake in Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock valued at $144,000 after buying an additional 55 shares during the last quarter. Finally, Invictus RG acquired a new stake in Stericycle during the first quarter valued at about $145,000. 96.51% of the stock is owned by institutional investors.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.